|
|
№7 / 2022
|
|
Yu.I. Khruleva, I.I. Amergulov, N.V. Likhodey, A.S. Dzyuba, Yu.P. Sych, M.G. Pavlova
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
|
№7 / 2022
|
|
I.B. Zhurtova, L.V. Elgarova, A.M. Gubachikova
Immune-mediated endocrine adverse events during treatment with immune checkpoint inhibitors: a clinical case of nivolumab-induced thyroiditis
|
№7 / 2022
|
|
A.V. Androsova, R.V. Orlova, A.K. Ivanova, N.P. Belyak, S.I. Kutukova, A.A. Varankina
The role of some factors of systemic inflammation in the course of gastrointestinal neuroendocrine tumors
|
№7 / 2022
|
|
N.P. Belyak, R.V. Orlova, S.I. Kutukova, Yu.V. Pelipas, A.V. Androsova, N.V. Zhukova
Pathological regression as an indicator of the effectiveness of perioperative FLOT/FOLFOX in patients with resectable gastric cancer
|
№7 / 2022
|
|
I.V. Poddubnaya, N.A. Ognerubov, T.S. Antipova
Thymus hyperplasia after lymphoma drug therapy: the role of PET/CT
|
№7 / 2022
|
|
O.D. Guryeva, M.I. Savelyeva, T.T. Valiev
Influence of pharmacogenetic parameters on clinical variants of methotrexate toxicity in acute lymphoblastic leukemia in children
|
№7 / 2022
|
|
A.V. Andreeva, M.B. Antsiferov
Evaluation of the effectiveness of combination therapy with somatostatin analogues and D2-dopamine receptor agonists in the treatment of persistent or recurrent course of Cushing’s disease
|
№7 / 2022
|
|
S.A. Protsenko, G.M. Teletaeva, D.Kh. Latipova, A.I. Semenova, A.V. Novik, Yu.I. Komarov, Sh.A. Dzhalilova, A.Yu. Malygin, E.A. Degtiareva
The use of pazopanib in the treatment of disseminated soft tissue sarcoma: personal experience
|
№7 / 2022
|
|
He Mingze, Zeng Zitong
Modern approaches to the treatment of muscle-invasive bladder cancer
|
№7 / 2022
|
|
R.S. Pesotsky, V.F. Semiglazov, A.I. Tseluyko, M.D. Sokolova, V.V. Mortada, T.T. Tabagua, P.V. Krivorotko
Treatment of HER2-positive early (minimal) breast cancer
|
№7 / 2022
|
|
Sh.R. Abdulaeva, T.Yu. Semiglazova, A.S. Artemyeva, A.G. Kudaibergenova, S.M. Sharashenidze, A.I. Tseluyko, R.M. Paltuev, V.V. Semiglazov, P.V. Krivorotko, V.F. Semiglazov
Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer
|
№7 / 2022
|
Русский
